Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Peer-spectives
Filter by Topic
ASCO’s Value Framework
Commentary
Employers’ Perspective
Letter to our Readers
Oncologist–Patient Communication
Patient Communication
Patient Perspective
Payer’s Perspective
Practice Management
Testimonials
The Patient Perspective
Value in Oncology
Value Propositions
VBCC Perspectives
Ginger Root Cost-Effective for Preventing Colon Cancer
Value Propositions
,
Value Peer-spectives
October 2011, Vol 2, No 6
In a new study funded by the National Cancer Institute and the University of Michigan Clinical Research Center, inexpensive ginger supplements reduced markers of colon inflammation, indicating that ginger root may be beneficial in preventing colon cancer (Zick SM, et al. Cancer Prev Res [Phila]. 2011 Oct 11. Epub ahead of print).
Read Article
US Patients Get New Cancer Drugs Faster than in Europe
Value Propositions
,
Value Peer-spectives
October 2011, Vol 2, No 6
Read Article
PET Imaging an Effective Tool for Tailoring Therapy in Advanced Lung Cancer
Value Propositions
,
Value Peer-spectives
October 2011, Vol 2, No 6
Positron emission tomography (PET) is a promising approach for differentiating which patients with inoperable lung cancer will and will not benefit from additional treatment after standard chemotherapy/radiation therapy.
Read Article
How to Assess the Value of Clinical Interventions
Value Propositions
,
Value Peer-spectives
October 2011, Vol 2, No 6
Another report in the same issue of the Annals of Internal Medicine focuses on the relevance of 3 concepts that can help in understanding the value of clinical interventions for those involved in clinical decisions (Owens DK, et al. Ann Intern Med. 2011;154:174-180).
Read Article
Value of Cost-Effectiveness Analyses for Clinical Practice Outlined by NICE
Value Propositions
,
Value Peer-spectives
October 2011, Vol 2, No 6
The National Institute for Health and Clinical Excellence (NICE) has issued a report (Wonderling D, et al. Ann Intern Med. 2011;154:758-765) explaining the process and value of cost-effectiveness assessments and how these inform recommendations and decisions regarding clinical questions made by the UK National Clinical Guidelines Centre.
Read Article
Personalized Approach to Mammography Most Cost-Effective, but at What Risk to Women?
Value Propositions
,
Value Peer-spectives
August 2011, Vol 2, No 5
The most recent mammography screening recommendations call on women to begin annual screening for breast cancer at age 40 years, regardless of their risk for the disease.
Read Article
FDA Grants Priority Review for Ruxolitinib for the Treatment of Myelofibrosis
Value Propositions
,
Value Peer-spectives
August 2011, Vol 2, No 5
The US Food and Drug Administration (FDA) has granted priority review for the investigational drug ruxolitinib as a potential treatment for patients with myelofibrosis, a blood cancer with few treatment options.
Read Article
Value of Screening High-Risk Individuals for Lung Cancer Confirmed, but Who Will Pay for It?
Value Propositions
,
Value Peer-spectives
August 2011, Vol 2, No 5
New results from the National Lung Cancer Screening Trial have shown that in individuals at high risk for lung cancer, screening with lowdose computed tomography (CT) significantly reduces mortality in this subpopulation (N Engl J Med. 2011;365:395-409).
Read Article
NICE Backs Value of Thalidomide, Bortezomib for Multiple Myeloma
Value Propositions
,
Value Peer-spectives
August 2011, Vol 2, No 5
In July, the United Kingdom’s National Institute for Health and Clinical Excellence (NICE) approved the use of thalidomide (Thalomid) for the first-line treatment of multiple myeloma in patients in whom high-dose chemotherapy with stem-cell transplantation is deemed inappropriate.
Read Article
Inexpensive Immunochemical Stool Test Effective Option for Colon Cancer Screening
Value Propositions
,
Value Peer-spectives
August 2011, Vol 2, No 5
The immunochemical fecal occult blood test (iFOBT), a new version of the traditional FOBT, has demonstrated 90% specificity in detecting colon growths.
Read Article
Page 13 of 16
7
8
9
10
11
12
13
14
15
16
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma